Position in CRBU
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,179,812
+$2,245,691 QoQ
Shares Held
2,374,894
+133.3% QoQ
Ownership
2.22%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 137 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,415,676 across 520 Biotechnology names. CRBU ranks #258 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CRBU
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,179,812 | 2,374,894 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,934,121 | 1,017,959 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,553,131 | 976,813 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $2,295,342 | 985,126 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,235,970 | 980,929 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,875,236 | 2,053,929 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,136,107 | 1,972,395 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,979,667 | 2,030,443 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,125,283 | 1,905,661 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $9,468,820 | 1,842,183 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $10,283,333 | 1,794,648 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,538,733 | 1,577,141 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,724,091 | 1,111,551 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,679,703 | 1,069,624 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,474,598 | 1,030,987 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $10,395,653 | 985,370 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,664,017 | 674,773 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,955,589 | 648,757 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,457,026 | 361,632 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $8,168,672 | 342,215 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||